What is Barclays's price target for PAHC?

Barclays's latest stated price target for Phibro Animal Health Corporation (PAHC) is $22, from its action on Jul 25, 2022.

What is Barclays's rating on PAHC?

Barclays rates PAHC Underweight, a bearish rating, as of Jul 25, 2022.

When did Barclays last change its view on PAHC?

On Jul 25, 2022, Barclays downgrades to Underweight from Equal Weight, price target $22.

Analyst firms · Barclays · PAHC

Barclays PAHC price target and rating history

Phibro Animal Health Corporation (PAHC) · Health Care

Barclays rates Phibro Animal Health Corporation (PAHC) Underweight with a $22 price target, as of its latest action on Jul 25, 2022. It has published 3 rating actions on PAHC since July 2021, including 1 upgrade and 2 downgrades.

Current rating: Underweight
Price target: $22
Median target, all firms: Too few
Actions on PAHC: 3

Barclays price target on PAHC

Barclays price target on PAHC, each point a stated target, July 2021 to July 2022.

Every Barclays rating on PAHC

Jul 25, 2022
DowngradeBarclays downgrades to Underweight from Equal Weight, price target $22
Jan 10, 2022
UpgradeBarclays upgrades to Equal-Weight from Underweight, price target $23
Jul 7, 2021
DowngradeBarclays downgrades to Underweight from Equal-Weight, price target $23

Questions about Barclays and PAHC

What is Barclays's price target for PAHC?: Barclays's latest stated price target for Phibro Animal Health Corporation (PAHC) is $22, from its action on Jul 25, 2022.
What is Barclays's rating on PAHC?: Barclays rates PAHC Underweight, a bearish rating, as of Jul 25, 2022.
When did Barclays last change its view on PAHC?: On Jul 25, 2022, Barclays downgrades to Underweight from Equal Weight, price target $22.

All Barclays ratings PAHC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.